NCT03232268View on ClinicalTrials.gov

HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 9, 2018

Primary Completion Date

March 9, 2027

Study Completion Date

March 9, 2027

Conditions
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Interventions
BIOLOGICAL

HLA-mismatched microtransplantation

3 administrations of hematopoietic stem cells without immunosupression

Trial Locations (1)

13009

Institut Paoli Calmettes, Marseille

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER